Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
783.76B | 795.27B | 851.96B | 733.01B | 551.29B | 508.25B | Gross Profit |
281.55B | 266.30B | 325.41B | 295.63B | 201.96B | 182.16B | EBIT |
144.99B | 141.92B | 191.36B | 183.24B | 112.51B | 88.35B | EBITDA |
205.00B | 190.92B | 240.55B | 230.32B | 157.62B | 134.26B | Net Income Common Stockholders |
137.60B | 133.16B | 170.59B | 155.27B | 94.01B | 73.37B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
579.05B | 539.08B | 529.23B | 601.22B | 586.78B | 532.56B | Total Assets |
1.92T | 1.93T | 1.87T | 1.78T | 1.63T | 1.51T | Total Debt |
0.00 | 0.00 | 5.11B | 2.44B | 2.16B | 1.82B | Net Debt |
-562.55B | -522.98B | -507.42B | -421.08B | -427.62B | -404.04B | Total Liabilities |
212.44B | 206.84B | 245.98B | 234.09B | 189.64B | 149.63B | Stockholders Equity |
1.69T | 1.71T | 1.62T | 1.54T | 1.43T | 1.36T |
Cash Flow | Free Cash Flow | ||||
33.80B | 117.88B | 52.44B | 91.22B | 96.23B | 69.44B | Operating Cash Flow |
48.28B | 171.76B | 99.50B | 125.58B | 118.00B | 144.87B | Investing Cash Flow |
10.10B | -13.56B | -78.00B | -53.93B | -16.77B | -84.32B | Financing Cash Flow |
-33.41B | -122.51B | -127.92B | -89.15B | -53.13B | -140.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥3.59T | 9.10 | 4.13% | 5.86% | 1.40% | ||
78 Outperform | $4.39T | 23.06 | 10.13% | 0.85% | -0.91% | 52.93% | |
75 Outperform | $9.45T | 9.01 | 11.94% | 3.73% | -5.94% | 24.47% | |
73 Outperform | ¥3.18T | 23.19 | 2.63% | -3.52% | -0.04% | ||
71 Outperform | ¥15.62T | 27.41 | 10.16% | 1.22% | -4.69% | -27.45% | |
67 Neutral | €5.31T | 15.17 | 9.27% | 1.98% | 4.88% | 34.48% | |
62 Neutral | $4.13B | 11.17 | 5.46% | 215.76% | 4.12% | -8.54% |